drugset / Trial / NCT06680466

A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery

NCT06680466

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Primary Objective: To explore the analgesic efficacy of YZJ-4729 compared with placebo in patients with acute postoperative pain following abdominal surgery. Secondary Objective: To explore the analgesic efficacy and safety of YZJ-4729 compared with placebo and morphine in patients with acute postoperative pain following abdominal surgery.

Timeline

Start
2023-12-26
Primary completion
2024-07-15
Completion
2024-08-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified
Subject YZJ-4729 Unknown

Indications

No indication recorded.